Particularly, ABCB1 and ABCG2 are known to mediate MDR against a variety of structurally different anticancer drugs [8,10,11] with ABCG2 also being a well-recognized stem cell marker in PCa [15]. This evidence concerns the gene ABCB1 and posterior cortical atrophy.